Comparative systems analysis of the secretome of the opportunistic pathogen Aspergillus fumigatus and other Aspergillus species

被引:0
作者
R. P. Vivek-Ananth
Karthikeyan Mohanraj
Muralidharan Vandanashree
Anupam Jhingran
James P. Craig
Areejit Samal
机构
[1] Homi Bhabha National Institute (HBNI),The Institute of Mathematical Sciences (IMSc)
[2] Stony Brook University,undefined
[3] Stony Brook,undefined
来源
Scientific Reports | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Aspergillus fumigatus and multiple other Aspergillus species cause a wide range of lung infections, collectively termed aspergillosis. Aspergilli are ubiquitous in environment with healthy immune systems routinely eliminating inhaled conidia, however, Aspergilli can become an opportunistic pathogen in immune-compromised patients. The aspergillosis mortality rate and emergence of drug-resistance reveals an urgent need to identify novel targets. Secreted and cell membrane proteins play a critical role in fungal-host interactions and pathogenesis. Using a computational pipeline integrating data from high-throughput experiments and bioinformatic predictions, we have identified secreted and cell membrane proteins in ten Aspergillus species known to cause aspergillosis. Small secreted and effector-like proteins similar to agents of fungal-plant pathogenesis were also identified within each secretome. A comparison with humans revealed that at least 70% of Aspergillus secretomes have no sequence similarity with the human proteome. An analysis of antigenic qualities of Aspergillus proteins revealed that the secretome is significantly more antigenic than cell membrane proteins or the complete proteome. Finally, overlaying an expression dataset, four A. fumigatus proteins upregulated during infection and with available structures, were found to be structurally similar to known drug target proteins in other organisms, and were able to dock in silico with the respective drug.
引用
收藏
相关论文
共 344 条
[1]  
Paulussen C(2017)Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species Microbial Biotechnology 10 296-322
[2]  
Baddley JW(2009)Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network Journal of clinical microbiology 47 3271-3275
[3]  
Lass‐Flörl C(2005)Epidemiology and outcome of infections due to Aspergillus terreus: 10‐year single centre experience British journal of haematology 131 201-207
[4]  
Balajee SA(2009)Aspergillus alabamensis, a new clinically relevant species in the section Terrei Eukaryotic Cell 8 713-722
[5]  
Patterson TF(2016)Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America Clinical Infectious Diseases 63 e1-e60
[6]  
Lin SJ(2001)Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358-366
[7]  
Schranz J(2009)Aspergillosis New England Journal of Medicine 360 1870-1884
[8]  
Teutsch SM(2010)What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis Rev Iberoam Micol 27 155-182
[9]  
Segal BH(2009)Pathogenesis of Aspergillus fumigatus in invasive aspergillosis Clinical microbiology reviews 22 447-465
[10]  
Abad A(2000)Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production J Allergy Clin Immunol 105 1185-1193